• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6分钟步行试验作为系统性硬化症患者结局指标缺乏特异性。

Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.

作者信息

Schoindre Yoland, Meune Christophe, Dinh-Xuan Anh Tuan, Avouac Jérôme, Kahan André, Allanore Yannick

机构信息

Université Paris Descartes, Service de Rhumatologie A, Département de Cardiologie, and Service Physiologie et Explorations Fonctionnelles, Hôpital Cochin, AP-HP, 75014 Paris, France.

出版信息

J Rheumatol. 2009 Jul;36(7):1481-5. doi: 10.3899/jrheum.081221. Epub 2009 Jun 1.

DOI:10.3899/jrheum.081221
PMID:19487260
Abstract

OBJECTIVE

The 6-minute walk test (6MWT) is an important prognostic tool in various cardiovascular diseases and has been considered as a surrogate endpoint. However, conflicting results have been reported in systemic sclerosis (SSc). Our objective was to evaluate the relationships of the 6-min walking distance (6MWD) and organ damage in SSc.

METHODS

Eighty-seven consecutive patients with SSc were included and prospectively investigated; they underwent 6MWT in addition to conventional assessment of possible lung, heart, kidney, skin, and muscle involvement, and disease activity scoring, severity, and quality of life determination.

RESULTS

Twenty-six patients (30%) had an abnormal 6MWT and the mean 6MWD was 461.8 +/- 103.0 m. When considering 6MWT as a binary variable - normal or abnormal - C-reactive protein (CRP) was the only independent variable associated with abnormal 6MWT. Considered as a continuous variable, the 6MWD was associated with measures of lung involvement and inflammation, with the activity and severity of disease, and also with quality of life; nevertheless, calcinosis was the only independent factor associated in multivariate analyses with a trend for an association for CRP.

CONCLUSION

The 6MWD relates to broad factors in SSc and these results raise doubts about the specificity of the 6MWD in this systemic disease, and its relevance to monitoring therapy.

摘要

目的

6分钟步行试验(6MWT)是多种心血管疾病的重要预后工具,被视为替代终点。然而,系统性硬化症(SSc)的相关研究结果存在矛盾。我们的目的是评估SSc患者6分钟步行距离(6MWD)与器官损害之间的关系。

方法

纳入87例连续的SSc患者并进行前瞻性研究;除了对可能的肺、心、肾、皮肤和肌肉受累情况进行常规评估以及疾病活动评分、严重程度和生活质量测定外,他们还接受了6MWT。

结果

26例患者(30%)6MWT异常,平均6MWD为461.8±103.0米。将6MWT视为二元变量(正常或异常)时,C反应蛋白(CRP)是与6MWT异常相关的唯一独立变量。将6MWD视为连续变量时,其与肺受累和炎症指标、疾病活动度和严重程度以及生活质量相关;然而,钙质沉着是多变量分析中唯一与CRP存在关联趋势的独立因素。

结论

SSc患者的6MWD与多种因素相关,这些结果对6MWD在这种全身性疾病中的特异性及其与监测治疗的相关性提出了质疑。

相似文献

1
Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.6分钟步行试验作为系统性硬化症患者结局指标缺乏特异性。
J Rheumatol. 2009 Jul;36(7):1481-5. doi: 10.3899/jrheum.081221. Epub 2009 Jun 1.
2
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.硬皮病中间质性肺疾病和肺动脉高压患者6分钟步行试验的局限性
J Rheumatol. 2009 Feb;36(2):330-6. doi: 10.3899/jrheum.080447. Epub 2009 Jan 22.
3
Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis.系统性硬化症患者左心室舒张功能障碍与 6 分钟步行试验的关系。
Int J Rheum Dis. 2011 Oct;14(4):379-83. doi: 10.1111/j.1756-185X.2011.01672.x. Epub 2011 Sep 21.
4
Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.六分钟步行距离作为系统性硬化症患者残疾和不适的标志物。
Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S53-9. Epub 2011 May 13.
5
Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.圣乔治呼吸问卷在评估系统性硬化症继发间质性肺病患者健康相关生活质量中的效度
Rheumatology (Oxford). 2007 Feb;46(2):296-301. doi: 10.1093/rheumatology/kel221. Epub 2006 Jul 28.
6
Percent predicted value for the 6-minute walk test: using norm-referenced equations to characterize severity in persons with CHF.6分钟步行试验的预测值百分比:使用常模参照方程来描述心力衰竭患者的严重程度。
J Card Fail. 2008 Feb;14(1):75-81. doi: 10.1016/j.cardfail.2007.09.005.
7
Clinical determinants of the 6-Minute Walk Test in bronchiectasis.支气管扩张症 6 分钟步行试验的临床决定因素。
Respir Med. 2009 May;103(5):780-5. doi: 10.1016/j.rmed.2008.11.005. Epub 2008 Dec 12.
8
Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.慢性心力衰竭患者的六分钟步行试验和心肺运动试验:临床与预后洞察的比较分析
Circ Heart Fail. 2009 Nov;2(6):549-55. doi: 10.1161/CIRCHEARTFAILURE.109.881326. Epub 2009 Sep 28.
9
Six-minute walk test in patients with Down syndrome: validity and reproducibility.唐氏综合征患者的6分钟步行试验:有效性与可重复性。
Arch Phys Med Rehabil. 2009 Aug;90(8):1423-7. doi: 10.1016/j.apmr.2009.02.015.
10
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.采用额氧饱和度测定的六分钟步行试验在评估硬皮病肺病中具有可靠性。
Respirology. 2012 May;17(4):647-52. doi: 10.1111/j.1440-1843.2012.02133.x.

引用本文的文献

1
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients?如何评估系统性硬化症患者的肺循环和右心腔?
Diagnostics (Basel). 2025 Apr 17;15(8):1029. doi: 10.3390/diagnostics15081029.
2
Validity and reliability of measurement of peripheral oxygen saturation during the 6-Minute Walk Test in patients with systemic sclerosis.系统性硬化症患者 6 分钟步行试验中周围血氧饱和度测量的有效性和可靠性。
Rheumatol Int. 2024 Apr;44(4):611-620. doi: 10.1007/s00296-024-05532-5. Epub 2024 Feb 10.
3
Independent Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
系统性硬化症相关肺动脉高压患者死亡率的独立预测因素:一项系统评价与Meta分析
Cureus. 2023 May 30;15(5):e39730. doi: 10.7759/cureus.39730. eCollection 2023 May.
4
Assessment of disease outcome measures in systemic sclerosis.系统性硬化病的疾病结局评估。
Nat Rev Rheumatol. 2022 Sep;18(9):527-541. doi: 10.1038/s41584-022-00803-6. Epub 2022 Jul 20.
5
The challenges and controversies of measuring disease activity in systemic sclerosis.系统性硬化症疾病活动度测量的挑战与争议
J Scleroderma Relat Disord. 2018 Jun;3(2):115-121. doi: 10.1177/2397198318765061. Epub 2018 Mar 27.
6
Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus.系统性红斑狼疮患者自我报告的行走、慢跑和跑步能力相关因素。
Arch Rheumatol. 2020 Dec 10;36(1):89-100. doi: 10.46497/ArchRheumatol.2021.8193. eCollection 2021 Mar.
7
Digital Measures That Matter to Patients: A Framework to Guide the Selection and Development of Digital Measures of Health.对患者重要的数字指标:指导健康数字指标选择与开发的框架
Digit Biomark. 2020 Sep 15;4(3):69-77. doi: 10.1159/000509725. eCollection 2020 Sep-Dec.
8
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease.需要采用整体方法治疗 SSc-ILD - 一种毁灭性疾病的成就与困惑。
Respir Res. 2020 Jul 23;21(1):197. doi: 10.1186/s12931-020-01459-0.
9
Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.系统性硬化症心脏并发症的认识、诊断和管理进展。
Curr Rheumatol Rep. 2019 Dec 7;21(12):68. doi: 10.1007/s11926-019-0867-0.
10
Factors associated with the 6-minute walk distance in patients with systemic sclerosis.与系统性硬化症患者 6 分钟步行距离相关的因素。
Arthritis Res Ther. 2017 Dec 15;19(1):279. doi: 10.1186/s13075-017-1489-4.